An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis (Q43984178)

28 November 2017

An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis (English)

1 reference

28 November 2017

1 reference

Lee Stanyer

1

1 reference

28 November 2017

D John Betteridge

series ordinal

2

1 reference

28 November 2017

Christopher C T Smith

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

28 November 2017

518

1 reference

28 November 2017

1-3

1 reference

28 November 2017

72-78

1 reference

Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Stimulated release of the beta-amyloid protein of Alzheimer's disease by normal human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Platelet secretion of beta-amyloid is increased in hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

4-Hydroxynonenal in the pathomechanisms of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Oxygen-mediated heterogeneity of apo-low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Measures of oxidative stress in heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

The oxidation hypothesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Modification of histidine residues in proteins by reaction with 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Protein oxidation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Platelets are the primary source of amyloid beta-peptide in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Lowry determination of protein in the presence of Triton X-100

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Detection of conjugated dienes by second derivative ultraviolet spectrophotometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902646-7

10.1016/S0014-5793(02)02646-7

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference